Table 2.
Autoantigen | Epitope(s) | Disease(s) | Commercially Available |
References |
---|---|---|---|---|
Desmoglein 1 | Ectodomain | Pemphigus | yes | [26, 178] |
Desmoglein 3 | Ectodomain | Pemphigus | yes | [26, 178] |
Envoplakin | Full-length | Paraneoplastic pemphigus | yes | [179-181] |
Periplakin | Full-length | Paraneoplastic pemphigus | no | [179, 180] |
BP180/collagen XVII | NC16A domain | Pemphigoid (IgG, IgE) | yes | [92, 95, 182-184] |
4xNC16A domain | Pemphigoid (IgG) | yes | [62] | |
Ectodomain | Pemphigoid (IgA) | no | [138] | |
BP230 | Fragments covering the full-lenght of BP230 | Pemphigoid (IgG) | yes | [93] |
Laminin Γ1 (p200) | C-terminal regiÓn | Anti-p200 pemphigoid (IgG) | no | [150] |
Collagen VII | NC1 domain | Epidermolysis bullosa acquisita (IgG) | yes | [185, 186] |
NC1, NC2 domains | Epidermolysis bullosa acquisita (IgG) | yes | [159] | |
NC1, NC2, hinge domains | Epidermolysis bullosa acquisita (IgG) | no | [161] | |
Transglutaminase, tissue |
Full-length | Dermatitis herpetiformis (IgA) | yes | [166, 187] |
Transglutaminase, tissue |
Deamidated gliadin-analogous fusion peptides | Dermatitis herpetiformis (IgA) | yes | [188] |
Transglutaminase, epidermal |
Dermatitis herpetiformis (IgA) | yes | [167] |